{
  "resourceType" : "ValueSet",
  "id" : "HIV.C.DE101",
  "meta" : {
    "profile" : ["http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablevalueset",
    "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablevalueset",
    "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-computablevalueset"]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet HIV.C.DE101</b></p><a name=\"HIV.C.DE101\"> </a><a name=\"hcHIV.C.DE101\"> </a><a name=\"HIV.C.DE101-en-US\"> </a><ul><li>Include these codes as defined in <a href=\"CodeSystem-HIVConcepts.html\"><code>http://smart.who.int/hiv/CodeSystem/HIVConcepts</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46C.46DE102\">HIV.C.DE102</a></td><td>ATV/r</td><td>Alternative third drug of atazanavir/ritonavir (ATV/r)</td></tr><tr><td><a href=\"CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46C.46DE103\">HIV.C.DE103</a></td><td>DRV/r</td><td>Alternative third drug of darunavir/ritonavir (DRV/r)</td></tr><tr><td><a href=\"CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46C.46DE104\">HIV.C.DE104</a></td><td>LPV/r</td><td>Alternative third drug of lopinavir/ritonavir (LPV/r)</td></tr><tr><td><a href=\"CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46C.46DE105\">HIV.C.DE105</a></td><td>RAL</td><td>Alternative third drug of raltegravir (RAL)</td></tr></table></li></ul></div>"
  },
  "url" : "http://smart.who.int/hiv/ValueSet/HIV.C.DE101",
  "version" : "0.2.0",
  "name" : "HIVCDE101",
  "title" : "Alternative third PEP drug ValueSet",
  "status" : "active",
  "experimental" : true,
  "date" : "2024-08-05T14:13:53+00:00",
  "publisher" : "WHO",
  "contact" : [{
    "name" : "WHO",
    "telecom" : [{
      "system" : "url",
      "value" : "http://who.int"
    }]
  }],
  "description" : "Value set of alternative third drug for PEP",
  "compose" : {
    "include" : [{
      "system" : "http://smart.who.int/hiv/CodeSystem/HIVConcepts",
      "concept" : [{
        "code" : "HIV.C.DE102",
        "display" : "ATV/r"
      },
      {
        "code" : "HIV.C.DE103",
        "display" : "DRV/r"
      },
      {
        "code" : "HIV.C.DE104",
        "display" : "LPV/r"
      },
      {
        "code" : "HIV.C.DE105",
        "display" : "RAL"
      }]
    }]
  }
}